Antioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina.
about
Novel Nrf2 activators from microbial transformation products inhibit blood-retinal barrier permeability in rabbits.Differential subcellular Ca2+ signaling in a highly specialized subpopulation of astrocytes.Flos Puerariae Extract Ameliorates Cognitive Impairment in Streptozotocin-Induced Diabetic Mice.Mutated myocilin and heterozygous Sod2 deficiency act synergistically in a mouse model of open-angle glaucoma.In Vivo Imaging of Retinal Oxidative Stress Using a Reactive Oxygen Species-Activated Fluorescent ProbeN-Acetylcysteine Amide Protects Against Oxidative Stress-Induced Microparticle Release From Human Retinal Pigment Epithelial CellsNADPH Oxidase Contributes to Photoreceptor Degeneration in Constitutively Active RAC1 Mice.Drusen maculopathy: a risk factor for visual deterioration.Mechanisms involved in the development of diabetic retinopathy induced by oxidative stress.Oxidative stress and diabetic retinopathy: development and treatment.Thinning of the RPE and choroid associated with T lymphocyte recruitment in aged and light-challenged mice.Flavonoid Naringenin Attenuates Oxidative Stress, Apoptosis and Improves Neurotrophic Effects in the Diabetic Rat Retina.Neurotrophin-conjugated nanoparticles prevent retina damage induced by oxidative stress.Functionality of cow milk naturally enriched with polyunsaturated fatty acids and polyphenols in diets for diabetic rats.
P2860
Q35111445-AC955228-779D-4033-92A9-C1A7017700DDQ35137472-0EE4A585-89CA-460D-BB16-9FC361AC030EQ35594774-FA8BC86B-B3BF-4698-92BD-FD5478A7AD4AQ35662064-26EB68FC-5F81-4D12-A8A8-A487CFE9B1A6Q35766820-C6614B76-ACD9-47B5-88BF-096291FC2673Q36531479-3A9CAE3C-9918-4C80-AE89-1F1366155DEEQ37420843-1C77D5C7-BE70-45AA-9F18-9EA20664D083Q38786743-49C61D79-59DF-4946-9558-608DFEFD165CQ38897854-F71F8AD2-05F0-41A9-876C-07CD40327E3CQ39269643-17B5E3BD-9FFB-44DC-9561-77DDC6B64B90Q43065738-80A16FA6-A533-4FC5-B0E4-C44D24F52671Q46500518-3176C380-2250-4879-85C1-1200E46F1BD6Q47446737-B35C03ED-08D9-4298-9093-BD20662BD8F2Q55093009-6159E170-9F38-449D-8E85-37DDC249C2E6
P2860
Antioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antioxidant drug therapy appro ...... hronic diseases of the retina.
@en
Antioxidant drug therapy appro ...... hronic diseases of the retina.
@nl
type
label
Antioxidant drug therapy appro ...... hronic diseases of the retina.
@en
Antioxidant drug therapy appro ...... hronic diseases of the retina.
@nl
prefLabel
Antioxidant drug therapy appro ...... hronic diseases of the retina.
@en
Antioxidant drug therapy appro ...... hronic diseases of the retina.
@nl
P2093
P2860
P356
P1476
Antioxidant drug therapy appro ...... hronic diseases of the retina.
@en
P2093
Andrew J Payne
Nancy Kunjukunju
Peter Koulen
P2860
P304
P356
10.3390/IJMS15021865
P407
P5008
P577
2014-01-27T00:00:00Z